Loading data
THRMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.5 bn USD | 1.46 bn USD | 1.47 bn USD | 1.2 bn USD | 1.05 bn USD |
| Cost of revenue | 1.14 bn USD | 1.09 bn USD | 1.12 bn USD | 931.01 m USD | 742.52 m USD |
| Gross profit | 362.18 m USD | 366.43 m USD | 351.62 m USD | 273.65 m USD | 303.63 m USD |
| Research and development expense | 94.76 m USD | 88.7 m USD | 94.36 m USD | 85.72 m USD | 75.21 m USD |
| Selling, general and administrative expense | 170.05 m USD | 155.11 m USD | 155.58 m USD | 132.69 m USD | 109.55 m USD |
| Operating profit | 82.7 m USD | 107.02 m USD | 77.44 m USD | 48.31 m USD | 115.01 m USD |
| Profit before tax | 35.84 m USD | 102.27 m USD | 54.95 m USD | 38.38 m USD | 113.85 m USD |
| Income tax expense | 17.55 m USD | 37.32 m USD | 14.61 m USD | 13.94 m USD | 20.42 m USD |
| Net income (reported basis) | 18.3 m USD | 64.9 m USD | 40.3 m USD | 24.4 m USD | 93.4 m USD |
| Basic earnings per share | 0.6 USD/share | 2.08 USD/share | 1.23 USD/share | 0.74 USD/share | 2.82 USD/share |
| Diluted earnings per share | 0.59 USD/share | 2.06 USD/share | 1.22 USD/share | 0.73 USD/share | 2.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.